Analysis Metabolite Name Measured Value Units CASE_CONTROL Chemotherapy Drug Race TIMEPOINT Tamoxyfen Taxane
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+2366Peak areaCase Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+2812Peak areaControl N Exemestane Black 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+3227Peak areaCase N Exemestane Black 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+3707Peak areaCase N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+4413Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+4640Peak areaCase N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+4738Peak areaCase N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+4800Peak areaControl N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+4862Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+4885Peak areaControl N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+4963Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+5067Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+5098Peak areaControl Y Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+5227Peak areaCase Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+5569Peak areaControl Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+5592Peak areaCase N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+5703Peak areaCase N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+6025Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+6379Peak areaControl Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+6592Peak areaControl N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+6638Peak areaControl Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+6713Peak areaControl N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+7010Peak areaCase N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+7467Peak areaCase N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+7469Peak areaCase Y Exemestane White 3 Month Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+7478Peak areaCase N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+7518Peak areaControl Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+7588Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+7762Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+7939Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+8070Peak areaControl N Letrozole Black Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+8081Peak areaCase N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+8086Peak areaCase N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+8153Peak areaCase N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+8278Peak areaCase N Exemestane Black Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+8374Peak areaCase N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+8417Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+8518Peak areaCase N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+8800Peak areaCase N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+9006Peak areaCase N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+9219Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+9270Peak areaControl N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+9731Peak areaCase Y Exemestane White Baseline Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+9785Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+10289Peak areaControl N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+10386Peak areaControl Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+10449Peak areaControl Y Exemestane White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+10454Peak areaControl Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+10658Peak areaControl Y Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+10661Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+10767Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+10770Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+11577Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+11604Peak areaControl Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+11986Peak areaControl Y Exemestane White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+12002Peak areaControl N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+12690Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+13203Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+13318Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+13768Peak areaControl N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+14119Peak areaCase N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+14647Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+14766Peak areaCase N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+15999Peak areaControl N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+16100Peak areaCase N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+16237Peak areaControl Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+16388Peak areaControl Y Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+16577Peak areaControl N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+17071Peak areaCase N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+17979Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+18564Peak areaControl N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+19136Peak areaCase N Letrozole Black 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+19856Peak areaCase Y Exemestane White Baseline Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+19878Peak areaCase Y Exemestane White 3 Month Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+19929Peak areaCase N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+21163Peak areaCase Y Exemestane Black Baseline N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+21874Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+21959Peak areaControl N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+22010Peak areaControl Y Exemestane White Baseline Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+24337Peak areaControl N Exemestane Black Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+24787Peak areaControl Y Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+25054Peak areaCase Y Exemestane Black 3 Month N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+26580Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+26723Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+28677Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+32311Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+33509Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+36011Peak areaCase Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+37780Peak areaControl N Letrozole Black 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+52518Peak areaControl N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+55011Peak areaControl N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+60374Peak areaCase Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+63725Peak areaCase N Letrozole Black Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+68551Peak areaControl Y Exemestane White 3 Month Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+75087Peak areaCase N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+87560Peak areaCase N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+102351Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+135064Peak areaControl Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+138773Peak areaControl Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+1254532Peak areaControl Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+1771Peak areaControl Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+2907Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+3261Peak areaControl Y Exemestane White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+3519Peak areaCase N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+3578Peak areaCase Y Exemestane White 3 Month Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+3895Peak areaCase N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+4185Peak areaControl Y Exemestane White 3 Month Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+4609Peak areaControl N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+4739Peak areaControl Y Exemestane White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+5042Peak areaControl Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+5127Peak areaCase Y Exemestane Black Baseline N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+6081Peak areaControl Y Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+6106Peak areaControl N Exemestane Black Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+6157Peak areaControl N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+6214Peak areaControl Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+6611Peak areaControl N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+6829Peak areaControl N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+6924Peak areaCase N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+7355Peak areaCase N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+7356Peak areaCase N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+8927Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+10101Peak areaControl N Letrozole Black Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+10959Peak areaCase Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+12078Peak areaCase N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+12139Peak areaCase N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+12436Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+12716Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+12956Peak areaControl N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+13363Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+14085Peak areaCase N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+14628Peak areaControl N Exemestane Black 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+14659Peak areaCase N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+14862Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+15095Peak areaControl Y Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+15921Peak areaControl N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+16014Peak areaControl Y Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+16609Peak areaCase N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+16656Peak areaControl Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+16850Peak areaCase N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+17475Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+17583Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+18342Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+19151Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+19209Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+19233Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+19467Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+20331Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+21481Peak areaControl Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+22505Peak areaCase Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+23097Peak areaCase N Letrozole Black Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+23711Peak areaControl N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+25131Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+25567Peak areaCase N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+26075Peak areaControl N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+27054Peak areaControl Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+27690Peak areaCase N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+29663Peak areaControl N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+30196Peak areaControl Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+30656Peak areaControl N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+31320Peak areaCase N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+31936Peak areaCase Y Exemestane Black 3 Month N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+34005Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+34006Peak areaCase N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+36229Peak areaCase N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+36258Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+37612Peak areaControl N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+38225Peak areaControl N Letrozole Black 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+39633Peak areaCase N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+41818Peak areaControl N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+43318Peak areaCase Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+45847Peak areaCase N Letrozole White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+50354Peak areaCase Y Exemestane White Baseline Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+52559Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+262878Peak areaControl Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+Peak areaCase N Exemestane Black 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+Peak areaCase N Exemestane Black Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+Peak areaCase N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+Peak areaCase N Letrozole Black 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+Peak areaCase N Letrozole White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+Peak areaCase N Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+Peak areaCase N Letrozole White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+Peak areaCase Y Exemestane White 3 Month Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+Peak areaCase Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+Peak areaCase Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+Peak areaCase Y Exemestane White Baseline Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+Peak areaControl N Exemestane White 3 Month N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+Peak areaControl N Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+Peak areaControl N Exemestane White Baseline N N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+Peak areaControl N Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+Peak areaControl Y Exemestane White Baseline N Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+Peak areaControl Y Exemestane White Baseline Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+Peak areaControl Y Exemestane White Baseline Y Y
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+Peak areaControl Y Letrozole White 3 Month Y N
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+Peak areaControl Y Letrozole White 3 Month Y Y

Return to search page
  logo